We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




DNA Microarray Detects 18 Important Human Blood Protozoan Species

By LabMedica International staff writers
Posted on 22 Dec 2016
Accurate detection of blood protozoa from clinical samples is important for diagnosis, treatment and control of related diseases and developing a rapid, simple, and convenient detection method for protozoan detection is an urgent need.

Blood protozoa are single-cell organisms that often have flagella, cilia or other structures that help them move. More...
They sometimes form parasitic relationships with humans and cause diseases or infections. The most common blood protozoa in humans, animals, and vectors include Plasmodium, Leishmania, Trypanosoma, Toxoplasma gondii and Babesia.

Scientists at Fudan University (Shanghai, PR China) and their colleagues collected a total of 438 samples from humans, animals and vectors from August 2012 to December 2014 as well as 100 blood samples from healthy individuals. Reference blood protozoan samples were either stored in the laboratory or kindly provided by different partner laboratories. Blood smears were prepared for each clinical blood sample and were examined under an oil immersion lens at a total magnification of ×1000 for presence of blood protozoa.

The whole blood that was suspected infected Leishmania from human and canine was also tested by the Kalazar Detect dipstick, a recombinant k39 antigen-based immunochromatographic strip, to detect anti-leishmanial antibodies (InBios International, Seattle, WA, USA). The team performed microarray assays simultaneously that identified 18 species of common blood protozoa based on the differences in respective target genes. A total of 20 specific primer pairs and 107 microarray probes were selected according to conserved regions, which were designed to identify 18 species in five blood protozoan genera.

The scientists found that the positive detection rate of the microarray assay was 91.8% (402/438). Sensitivity and specificity for blood protozoan detection ranged from 82.4% to 100.0% and 95.1% to 100.0%, respectively. Positive predictive value (PPV) and negative predictive value (NPV) ranged from 20.0% to 100.0% and 96.8% to 100.0%, respectively. Youden index varied from 0.82 to 0.98. The detection limit of the DNA microarrays ranged from 200 to 500 copies/reaction, which was similar to the polymerase chain reaction (PCR) findings. The concordance rate between microarray data and DNA sequencing results was 100%.

The authors concluded that overall, the microarray platform can provide a convenient, accurate and reliable diagnostic tool for the identification of 18 of the most common blood protozoan species. The system should be widely used in future detection assay and management of blood protozoan infections in busy hospitals and research institutes, and would help in disease control and prevention plans. The study was published on December 2, 2016, in the Public Library of Science Neglected Tropical Diseases.

Related Links:
Fudan University
InBios International

New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Drug Test Kit
DrugCheck 3000
New
Candida Glabrata Test
ELIchrom Glabrata
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.